![touchPODCAST](https://pbcdn1.podbean.com/imglogo/image-logo/9562868/touchPODCAST_image2000x2000.jpg)
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
![Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma](https://pbcdn1.podbean.com/imglogo/image-logo/9562868/touchPODCAST_image2000x2000_300x300.jpg)
24 hours ago
24 hours ago
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.
The experts
- Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
- Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
- Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma
![Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma](https://pbcdn1.podbean.com/imglogo/image-logo/9562868/touchPODCAST_image2000x2000_300x300.jpg)
24 hours ago
24 hours ago
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.
The experts
- Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
- Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
- Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit: https://touchhaematologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma
![Demystifying virology: The link between the HIV life cycle and ART](https://pbcdn1.podbean.com/imglogo/image-logo/9562868/touchPODCAST_image2000x2000_300x300.jpg)
2 days ago
2 days ago
touchEXPERT OPINIONS for touchINFECTIOUS DISEASES
Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV.
The experts
- Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, Leuven, Belgium
- Prof. José Arribas - La Paz Hospital, Madrid, Spain
- Prof. Antonella Castagna - Vita-Salute San Raffaele University, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is provided by touchIME.
For further information visit our website:
![Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies](https://pbcdn1.podbean.com/imglogo/image-logo/9562868/touchPODCAST_image2000x2000_300x300.jpg)
3 days ago
3 days ago
touchIN CONVERSATION for touchRESPIRATORY
Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments.
The experts
- Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain
- Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchrespiratoryime.org/her2_nsclc_testing_and_targeted_therapies/
![Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies](https://pbcdn1.podbean.com/imglogo/image-logo/9562868/touchPODCAST_image2000x2000_300x300.jpg)
3 days ago
3 days ago
touchIN CONVERSATION for touchONCOLOGY
Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments.
The experts
- Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain
- Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/her2_nsclc_testing_and_targeted_therapies/
![Early diagnosis and treatment of NMOSD: Practical insights](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9562868/7217_NEURO_Podcast_Thumbnail_800x800_niiwe6_300x300.png)
Friday Jul 19, 2024
Early diagnosis and treatment of NMOSD: Practical insights
Friday Jul 19, 2024
Friday Jul 19, 2024
touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights
Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.
The experts:
- Prof. John Chen - Mayo Clinic, Rochester, MN, USA
- Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Campus Mitte, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/nmosd_diagnosis_treatment
https://touchneurologyime.org/nmosd_diagnosis_treatment
![Early diagnosis and treatment of NMOSD: Practical insights](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog9562868/7217_OPHTH_Podcast_Thumbnail_800x800_ihkaza_300x300.png)
Friday Jul 19, 2024
Early diagnosis and treatment of NMOSD: Practical insights
Friday Jul 19, 2024
Friday Jul 19, 2024
touchIN CONVERSATION for touchOPTHAMOLOGY
Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.
The experts:
- Prof. John Chen - Mayo Clinic, Rochester, MN, USA
- Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchophthalmologyime.org/nmosd_diagnosis_treatment
https://touchneurologyime.org/nmosd_diagnosis_treatment
![Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 1 touchHAEMATOLOGY](https://pbcdn1.podbean.com/imglogo/image-logo/9562868/touchPODCAST_image2000x2000_300x300.jpg)
Wednesday Jul 17, 2024
Wednesday Jul 17, 2024
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
![Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 2 touchHAEMATOLOGY](https://pbcdn1.podbean.com/imglogo/image-logo/9562868/touchPODCAST_image2000x2000_300x300.jpg)
Wednesday Jul 17, 2024
Wednesday Jul 17, 2024
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Pathologist: Dr Eric Gars, Gainesville, FL, USA
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME
![Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team - Part 3 touchHAEMATOLOGY](https://pbcdn1.podbean.com/imglogo/image-logo/9562868/touchPODCAST_image2000x2000_300x300.jpg)
Wednesday Jul 17, 2024
Wednesday Jul 17, 2024
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient.
The multidisciplinary team
- HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USA
- Paediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USA
- Critical care pharmacist: Prof. Rob MacLaren, Denver, CO
This touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.